Skip to main content
NVDA-0.70%AAPL+0.73%GOOGL-2.28%MSFT-0.17%AMZN+0.02%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.66%TSLA-1.32%SKHY+7.05%MU-1.81%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.22%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.34%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.59%AUDJPY-1.51%USDJPY-1.35%EURJPY-1.30%GBPJPY-1.24%CADJPY-1.21%NZDCAD-0.99%GBPNZD+0.94%EURNZD+0.92%NZDUSD-0.86%AUDNZD+0.70%USDNOK+0.65%NZDCHF-0.63%USDZAR+0.53%EURNOK+0.53%CHFNOK+0.46%USDSEK+0.42%EURZAR+0.41%GBPTRY+0.41%GBPZAR+0.40%CADCHF+0.36%AUDCAD-0.33%GBPCHF+0.33%GBPHKD+0.32%EURSEK+0.29%AUDNOK+0.29%GBPMXN-0.28%EURCHF+0.28%USDTHB+0.28%NOKJPY-0.27%USDPLN+0.25%GBPAUD+0.25%USDCHF+0.25%AUDDKK-0.24%SGDJPY+0.24%CHFSEK+0.22%USDMXN+0.22%AUDSGD-0.22%EURAUD+0.21%AUDUSD-0.16%USDILS+0.16%USDSGD+0.15%EURHKD-0.14%PLNJPY+0.13%USDCAD-0.13%USDDKK+0.13%EURPLN+0.12%USDTRY+0.11%GBPUSD+0.10%EURCAD-0.10%EURCNH-0.08%AUDCHF+0.08%EURCZK-0.08%NZDMXN+0.07%GBPCAD-0.05%CHFSGD-0.04%EURUSD+0.04%EURGBP-0.04%USDCOP-0.04%EURSGD+0.03%USDCNH+0.02%NZDSGD+0.02%GBPSGD+0.02%USDHKD+0.01%EURDKK0.00%HG1-4.16%XPTUSD-3.63%XAGUSD-2.51%GAGUSD-2.51%COFFEE-2.48%SUGAR+1.85%USOIL+1.66%UKOIL+1.57%COTTON+0.98%S1+0.73%COCOA-0.72%C1+0.71%BTCUSD-0.58%ETHUSD-0.24%USDTUSD-0.06%XRPUSD-1.26%SOLUSD-0.43%TRXUSDT+0.50%ZECUSDT-1.89%DOGEUSD-1.09%XMRUSDT-1.13%LINKUSD+0.26%XLMUSD-0.97%BCHUSDT-2.60%LTCUSD-1.77%UNIUSD-2.02%TONUSD+24.88%HBARUSDT-1.05%SUIUSD-1.33%TAOUSDT-1.05%AAVEUSD-2.18%DOTUSDT-2.01%ICPUSDT-1.15%ONDOUSDT-1.98%WLDUSDT-1.47%ATOMUSDT-2.97%ARBUSDT-0.97%JUPUSDT-2.53%INJUSDT-2.13%STXUSDT-2.34%FETUSDT-2.59%TIAUSDT-0.08%PYTHUSDT-0.42%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.83%OPUSDT-0.99%POLUSDT-5.19%IOTAUSDT-2.94%AXSUSDT-1.82%FARTCOINUSDT-2.72%EOSUSDT-0.06%DYDXUSDT+1.06%ORDIUSDT-0.16%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.70%AAPL+0.73%GOOGL-2.28%MSFT-0.17%AMZN+0.02%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.66%TSLA-1.32%SKHY+7.05%MU-1.81%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.22%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.34%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.59%AUDJPY-1.51%USDJPY-1.35%EURJPY-1.30%GBPJPY-1.24%CADJPY-1.21%NZDCAD-0.99%GBPNZD+0.94%EURNZD+0.92%NZDUSD-0.86%AUDNZD+0.70%USDNOK+0.65%NZDCHF-0.63%USDZAR+0.53%EURNOK+0.53%CHFNOK+0.46%USDSEK+0.42%EURZAR+0.41%GBPTRY+0.41%GBPZAR+0.40%CADCHF+0.36%AUDCAD-0.33%GBPCHF+0.33%GBPHKD+0.32%EURSEK+0.29%AUDNOK+0.29%GBPMXN-0.28%EURCHF+0.28%USDTHB+0.28%NOKJPY-0.27%USDPLN+0.25%GBPAUD+0.25%USDCHF+0.25%AUDDKK-0.24%SGDJPY+0.24%CHFSEK+0.22%USDMXN+0.22%AUDSGD-0.22%EURAUD+0.21%AUDUSD-0.16%USDILS+0.16%USDSGD+0.15%EURHKD-0.14%PLNJPY+0.13%USDCAD-0.13%USDDKK+0.13%EURPLN+0.12%USDTRY+0.11%GBPUSD+0.10%EURCAD-0.10%EURCNH-0.08%AUDCHF+0.08%EURCZK-0.08%NZDMXN+0.07%GBPCAD-0.05%CHFSGD-0.04%EURUSD+0.04%EURGBP-0.04%USDCOP-0.04%EURSGD+0.03%USDCNH+0.02%NZDSGD+0.02%GBPSGD+0.02%USDHKD+0.01%EURDKK0.00%HG1-4.16%XPTUSD-3.63%XAGUSD-2.51%GAGUSD-2.51%COFFEE-2.48%SUGAR+1.85%USOIL+1.66%UKOIL+1.57%COTTON+0.98%S1+0.73%COCOA-0.72%C1+0.71%BTCUSD-0.58%ETHUSD-0.24%USDTUSD-0.06%XRPUSD-1.26%SOLUSD-0.43%TRXUSDT+0.50%ZECUSDT-1.89%DOGEUSD-1.09%XMRUSDT-1.13%LINKUSD+0.26%XLMUSD-0.97%BCHUSDT-2.60%LTCUSD-1.77%UNIUSD-2.02%TONUSD+24.88%HBARUSDT-1.05%SUIUSD-1.33%TAOUSDT-1.05%AAVEUSD-2.18%DOTUSDT-2.01%ICPUSDT-1.15%ONDOUSDT-1.98%WLDUSDT-1.47%ATOMUSDT-2.97%ARBUSDT-0.97%JUPUSDT-2.53%INJUSDT-2.13%STXUSDT-2.34%FETUSDT-2.59%TIAUSDT-0.08%PYTHUSDT-0.42%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.83%OPUSDT-0.99%POLUSDT-5.19%IOTAUSDT-2.94%AXSUSDT-1.82%FARTCOINUSDT-2.72%EOSUSDT-0.06%DYDXUSDT+1.06%ORDIUSDT-0.16%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
DT

Dianthus Therapeutics, Inc. (DNTH)

NASDAQ • Healthcare

$107.04
-$2.08 (-1.9%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$108.03
Day Range$105.95 - $110.24
Avg. Volume (3M)596.5K
Market Cap$5.9B
52 Week Range
$32.22$117.88
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$761K100%
Gross Profitminus cost of goods$761K100%

Fundamentals & Financials

Revenue (TTM)
$1.9M
Net Income (TTM)
-$29.9M
EPS (TTM)
-$0.13
ROA (TTM)
-2.47%
Current Ratio
26.1

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-45.9%Q1 2026-$1.43
+27.4%Q2 2026-$0.85
-6.3%Q3 2026-$0.9
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -6.3%

Dianthus Therapeutics’ EPS trailed consensus in the fiscal second quarter of 2026, reported Aug. 4, even as revenue rose 294.3% to about $761,000. Operating income was a loss of about $61.5 million, and net income was a loss of about $50.2 million, down 58.8% from a loss of about $31.6 million a year ago. EPS of -$0.90 trailed the -$0.85 estimate, -6%, and was down 2.3% from -$0.88 a year ago. Consensus for the next period calls for EPS of -$1.02 on revenue of $400,833.00.

View full earnings history

About Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing therapies for patients with severe autoimmune diseases. In qualitative terms, it is a clinical-stage healthcare company built around an early pipeline rather than commercialized products, with its work centered on two named candidates: claseprubart and DNTH212.

Name
Dianthus Therapeutics, Inc.
CEO
Marino Garcia
Website
dianthustx.com
Industry
Healthcare
Year Founded
2019
Employees
92

Today's Snapshot

AI-generated

The day ended with DNTH 1.9% lower at 107.04, while its sector was flat. Trading was busier than usual, with volume roughly twice its usual level.

Trading Volume

Above 10d avg 521.0K

1M

vs S&P 500 Today

Underperforming Market

-1.50%

Updated: September 9, 2026 at 20:16 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
DNTH currently presents a neutral technical picture as momentum and trend indicators are largely flat and conflicting. RSI and stochastic sit near midrange and MACD is near zero, suggesting limited directional conviction, while ADX around the mid-teens confirms a weak trend. Short-term moving averages are marginally above the price, yet medium- and long-term averages remain well below, showing longer-term support. Volume measures are mixed and ATR reflects moderate volatility, with the pivot close by. Technical takeaway: Neutral.
All signals
  • EMA (5 indicators)$77.93 - $108.53
    Buy
  • RSI (14)48.16
    Neutral
  • Stochastic %K (14, 3, 3)40.35
    Neutral
  • MACD Level (12, 26)0.29
    Neutral

Peers & Related Assets

ELVNEnliven Therapeutics, Inc.
$57.45-3.2%
TSHATaysha Gene Therapies, Inc.
$5.34-2.5%
ANABAnaptysBio, Inc.
$55.7-1.6%
SANASana Biotechnology, Inc.
$3.17-8.1%
ATAIAtai Beckley Inc.
NKTRNektar Therapeutics
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.